Eaglewings
Platinum Member
What the hell.
.Like this guy is going to cut ties with the BIG PHARMA who lines his pockets with money...
Our insurance is sky high because of these damn congress like him getting rich off of the Drug Companies and then turns their back on the jacking up high prices and corruption.
According to Maplight.org, all three companies have given multiple campaign donations, totaling between $13,000 and $15,000, each to the White House Pick Rep. Tom Marino, R-Pa, to be the Director of the Office of National Drug Control Policy (ONDCP) who wrote legislation that made it harder for the DEA to take companies off a registry that allows them to distribute controlled substances. If the companies were dealt this penalty, they could potentially incur a far greater financial hit than fines.
“This is the opposite of draining the swamp,” Dr. Andrew Kolodny, the co-director of Opioid Policy Research at Brandeis University and co-founder of Physicians for Responsible Opioid Prescribing (PROP), told International Business Times. “In the midst of a public health crisis [Trump] is putting at the helm of the ONDCP someone who has worked for the opioid lobby against efforts to bring the epidemic under control.”
Trump’s Drug Czar Pick Took Thousands In Donations From Drug Distributors
.Like this guy is going to cut ties with the BIG PHARMA who lines his pockets with money...
Our insurance is sky high because of these damn congress like him getting rich off of the Drug Companies and then turns their back on the jacking up high prices and corruption.
According to Maplight.org, all three companies have given multiple campaign donations, totaling between $13,000 and $15,000, each to the White House Pick Rep. Tom Marino, R-Pa, to be the Director of the Office of National Drug Control Policy (ONDCP) who wrote legislation that made it harder for the DEA to take companies off a registry that allows them to distribute controlled substances. If the companies were dealt this penalty, they could potentially incur a far greater financial hit than fines.
“This is the opposite of draining the swamp,” Dr. Andrew Kolodny, the co-director of Opioid Policy Research at Brandeis University and co-founder of Physicians for Responsible Opioid Prescribing (PROP), told International Business Times. “In the midst of a public health crisis [Trump] is putting at the helm of the ONDCP someone who has worked for the opioid lobby against efforts to bring the epidemic under control.”
Trump’s Drug Czar Pick Took Thousands In Donations From Drug Distributors
